Nanoparticles based on functional peptide self-assembly and conjugated with Toll-like receptor (TLR7 and TLR8) agonist effectively induced DC maturation and extended the duration of antigen presentation, so potentiating neoantigen-specific stem-like CD8+ T cells to optimize the anti-tumor immunity [149]. Here, CD8A is linked to neoplasm.